The integration of artificial intelligence (AI) into the healthcare system is changing how medical practices operate, particularly in medication management. AI supports clinicians and promises improvements in patient outcomes. However, using AI prescribing raises important concerns about data privacy and liability, which impact the decisions of medical practice administrators, owners, and IT managers across the United States.
By 2025, it was reported that 86% of healthcare providers used some form of AI technology. One of the most significant applications of AI is its ability to analyze large amounts of data to create personalized medication prescriptions. House Bill 238 seeks to classify some AI technologies as medical devices so they can meet strict regulatory standards before clinical use.
Supporters of AI claim these technologies can improve drug prescriptions by using patient data analytics to enhance decision-making. Benefits include fewer medication errors, improved patient safety, and better clinical efficiencies, which help reduce the administrative tasks faced by healthcare providers. The urgency to adopt AI-driven tools is seen in findings from the Medical Group Management Association (MGMA), which reports that 32% of medical practice leaders prioritized AI tools as their top focus, a rise from 13% in 2023.
Though supporters tout the potential advantages of AI systems, ethical implications and challenges must be addressed by administrators.
Data privacy is a significant issue in AI prescribing. AI applications in healthcare need access to large amounts of patient data, raising questions about how this information is collected, stored, and used. The reliance on patient data increases the risk of breaches, unauthorized access, and misuse, leading to regulatory requirements under frameworks like the Health Insurance Portability and Accountability Act (HIPAA) and the General Data Protection Regulation (GDPR).
Healthcare organizations should implement measures to safeguard patient privacy while utilizing AI systems. These measures can include careful contract terms with third-party vendors, strong encryption practices, regular audits, and staff training on data security. Since third-party vendors play key roles in AI application development, conducting due diligence is essential to ensure that selected partners are committed to data protection.
As AI systems become more independent, determining liability in cases of errors or negative outcomes creates a complex legal landscape. Traditional tort mechanisms like medical malpractice are uncertain when applied to AI decision-making processes, especially with “black-box” systems where the rationale behind decisions is unclear.
Current liability frameworks do not sufficiently address AI’s unpredictability, complicating the assignment of legal responsibility. Some experts suggest new legal models, including the concept of AI personhood that would allow AI to be held liable for negligence, or common enterprise liability, where all parties involved with an AI system would share responsibility for any harm or injuries resulting from its use.
The potential change in liability standards would require adjustments in the obligations of healthcare professionals using AI in their practices. It is crucial for practitioners to evaluate and validate the outputs generated by these systems. Modifying the standard of care to account for AI usage will be an essential step, ensuring that practitioners maintain their responsibility in making clinical decisions based on AI guidance.
For medical practice administrators, owners, and IT managers, understanding the impact of AI adoption on existing operations and patient interactions is essential. The legal environment surrounding AI prescribing is still changing, and adaptations will be needed to meet future regulations and expectations. Familiarity with emerging legislative frameworks, like the AI Bill of Rights and the NIST AI Risk Management Framework, will be important for ensuring compliance while advancing healthcare initiatives.
Informed consent is also a crucial aspect of AI-driven healthcare. Patients must understand that AI systems are part of their treatment plans and how these technologies use their personal data. Educating patients about the benefits and risks associated with AI-prescribed treatments promotes transparency and trust in both the technology and medical practitioners.
Even with the advantages of AI in improving patient care, healthcare providers must continuously evaluate and communicate the risks linked to its use. This can be challenging for practitioners used to traditional decision-making who may be hesitant to rely on AI systems.
AI-driven automation can significantly alleviate the administrative burdens that healthcare workers face daily. By streamlining repetitive tasks like appointment scheduling, patient data entry, and follow-up communications, medical practices can focus more on direct patient care.
For example, using AI medical scribes can assist healthcare professionals in managing documentation effectively. These AI systems record patient interactions accurately, reduce time spent on paperwork, and allow clinicians to dedicate more time to their patients. This leads to improved workflows and better patient interactions, which can enhance overall patient satisfaction.
AI’s role in managing chronic diseases shows how technology can assist both patients and clinicians. By consistently monitoring patients’ health conditions and adjusting treatment plans based on real-time data, AI helps ensure that drug regimens are effective and safe, reducing complications over time.
Additionally, AI can identify patterns in patient data to provide predictive insights, enabling healthcare providers to recognize potential health issues before they worsen. This proactive approach encourages patient engagement and adherence to treatment plans.
The economic benefits of implementing AI systems also become clear as they lower costs in healthcare delivery. Reduced operational costs, improved clinical outcomes, and scalable implementation across various healthcare settings enhance access to care, which is beneficial for both practitioners and patients.
Ongoing education for healthcare professionals about AI technologies is essential for cultivating relevant skills and knowledge. As medical practices evolve with AI integration, programs that focus on understanding AI’s analytical capabilities, functionalities, and limitations will be important.
Healthcare organizations should provide training for administrators and staff to aid the transition into AI-enhanced workflows. Professionals need to learn to balance their clinical judgment with AI’s data-driven insights for the best patient care.
Moreover, continuous discussions about the ethical use of AI in healthcare will help organizations stay alert to potential issues. Engaging staff in conversations about accountability in AI prescribing enhances collective responsibility and promotes a culture of transparency.
AI remains at the forefront of change in healthcare practices. To maximize its benefits, medical practice administrators need to stay engaged in discussions about data privacy, liability, and ethical issues related to AI technology. These considerations will evolve as technology advances, requiring a flexible approach to policy and practice.
Incorporating insights from healthcare and legislative leaders will create a solid framework for AI integration. Collaborating with technology providers, complying with legislative changes, and continuous education will prepare practices to handle the complexities of AI in healthcare.
By actively participating in the development of AI applications and recognizing their implications for patient care, medical practice leaders can uphold the integrity of healthcare while using new technologies to improve client health outcomes.
This engagement will help establish best practices for adopting AI technologies, addressing important concerns about data privacy and liability, and nurturing trust in the patient-provider relationship.
The Healthy Technology Act of 2025 is a bill introduced by Congressman David Schweikert aimed at allowing artificial intelligence (AI) systems to qualify as practitioners that can prescribe drugs, under specific conditions.
Key provisions include that AI must be approved by the FDA and the respective state must authorize its use for prescribing medication.
Proponents argue AI can reduce medication errors, enhance efficiency, provide personalized treatment, and alleviate physician burnout by automating routine tasks.
Critics raise concerns about the loss of human judgment, data privacy risks, potential fraud, exacerbation of biases, and liability issues with AI-related errors.
AI is transforming healthcare through applications like diagnostic imaging and AI-powered medical scribes that document encounters and manage records.
AI medical scribes automate documentation, reducing administrative burdens, improving accuracy, and allowing clinicians to devote more time to patient care.
The adoption of AI scribes has accelerated, with a significant increase in prioritization among medical practice leaders, reflecting their growing importance in healthcare.
AI offers benefits such as improved diagnostic accuracy, enhanced patient safety, and increased workflow efficiency, ultimately leading to better healthcare delivery.
With AI prescribing, ethical considerations include patient safety, the integrity of medical decisions, and maintaining the doctor-patient relationship.
Dr. Topol emphasizes that AI’s greatest potential lies in restoring the human connection and trust between patients and doctors, not just in reducing errors or workloads.
Simbo is using AI agents to automate all phone related workflows. Connect now to know more.
Schedule AI Agents Demo Now© Since 2019, Simbo AI.
